Clinical Trials Access Collaborative (CTAC)

Company

Clinical Trials Access Collaborative (CTAC)

Biotechnology Research Barriers That Prevent Communities of Color and Other Underrepresented Groups from Participating in and Benefiting from the Development of Life-saving Medical Treatments. 1 employees

Employees: 1

ctac.org LinkedIn

Clinical Trials Access Collaborative (CTAC) Overview

Headquarters: Barriers That Prevent Communities of Color and Other Underrepresented Groups from Participating in and Benefiting from the Development of Life-saving Medical Treatments.
Website: ctac.org
Industry: Biotechnology Research
Employees: 1
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

brings us closer to the world Dr. King dreamed of.

About Clinical Trials Access Collaborative (CTAC)

Clinical Trials Access Collaborative (CTAC) is a partnership committed to making medical research more accessible. Clinical trials are a crucial component to advancing medical research and improving patient outcomes. By expanding participation in clinical trials, communities across the U.S. will have the opportunity to participate in and benefit from the latest advancements in treatment while improving medical research. * CTAC presently is in the 501(c)(3) application process.